原著　英文　2017年

Safety of unsedated PEG placement using transoral ultrathin endoscopy in patients with amyotrophic lateral sclerosis.
Sato Y, Goshi S, Kawauchi Y, Nishigaki Y, Mizuno KI, Hashimoto S, Takeuchi M, Kobayashi M, Ozawa T, Nishizawa M, Aoyagi Y.
Nutr Neurosci. 2017 Jan;20(1):71-75.

Immunohistochemical differentiation of eosinophilic esophageal myositis from eosinophilic esophagitis.
Sato H, Nakajima N, Hasegawa G, Kawata Y, Sato Y, Suzuki K, Honma T, Terai S.
J Gastroenterol Hepatol. 2017 Jan;32(1):106-113.

Lipoprotein-X in cholestatic patients causes xanthomas and promotes foam cell formation in human macrophages.
Suzuki L, Hirayama S, Fukui M, Sasaki M, Hiroi S, Ayaori M, Terai S, Tozuka M, Watada H, Miida T.
J Clin Lipidol. 2017 Jan-Feb;11(1):110-118. 28391876.

Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis.
Sakaida I, Terai S, Nakajima K, Shibasaki Y, Tachikawa S, Tsubouchi H.
J Gastroenterol. 2017 Feb;52(2):229-236.

Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn's Disease Patients with Active Mucosal Lesions.
Suzuki K, Yokoyama J, Kawauchi Y, Honda Y, Sato H, Aoyagi Y, Terai S, Okazaki K, Suzuki Y, Sameshima Y, Fukushima T, Sugahara K, Atreya R, Neurath MF, Watanabe K, Yoneyama H, Asakura H.
J Crohns Colitis. 2017 Feb;11(2):221-228.

Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C.
Yamagiwa S, Ishikawa T, Waguri N, Sugitani S, Wakabayashi H, Ohkoshi S, Tsukishiro T, Takahashi T, Watanabe T, Terai S.
World J Hepatol. 2017 Feb;9(5):252-262.

Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel diseases.
Tominaga K, Yamagiwa S, Setsu T, Kimura N, Honda H, Kamimura H, Honda Y, Takamura M, Yokoyama J, Suzuki K, Wakai T, Terai S.

Re-evaluation of Phenotypic Expression in Differentiated-type Early Adenocarcinoma of the Stomach.
Hayakawa M, Nishikura K, Ajioka Y, Aoyagi Y, Terai S.
Pathol Int. 2017 Mar;67(3):131-140.

Muscle layer histopathology and manometry pattern of primary esophageal motility disorders including achalasia.
Nakajima N, Sato H, Takahashi K, Hasegawa G, Mizuno K, Hashimoto S, Sato Y, Terai S.
Neurogastroenterol Motil. 2017 Mar;29(3).

Long-term outcomes of colorectal endoscopic submucosal dissection in elderly patients.
Takahashi Y, Mizuno KI, Takahashi K, Sato H, Hashimoto S, Takeuchi M, Kobayashi M, Yokoyama J, Sato Y, Terai S.
Int J Colorectal Dis. 2017 Apr;32(4):567-573.

Development and use of a non-biomaterial model for hands-on training of endoscopic procedures.
Sato H, Mizuno KI, Sato Y, Hashimoto S, Hayashi K, Ikarashi S, Honda Y, Yokoyama J, Terai S. Ann Transl Med. 2017 Apr;5(8):182.

Proposed criteria to differentiate heterogeneous eosinophilic gastrointestinal disorders of the esophagus, including eosinophilic esophageal myositis.
Sato H, Nakajima N, Takahashi K, Hasegawa G, Mizuno KI, Hashimoto S, Ikarashi S, Hayashi K, Honda Y, Yokoyama J, Sato Y, Terai S.
World J Gastroenterol. 2017 Apr;23(13):2414-2423.

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.
Yamagiwa S, Ishikawa T, Waguri N, Sugitani S, Kamimura K, Tsuchiya A, Takamura M, Kawai H, Terai S.
Int J Med Sci. 2017 Apr;14(5):403-411.

BCL11B gene heterozygosity causes weight loss accompanied by increased energy consumption, but not defective adipogenesis, in mice.
Inoue J, Ihara Y, Tsukamoto D, Yasumoto K, Hashidume T, Kamimura K, Hirano S, Shimizu M, Kominami R, Sato R.
Biosci Biotechnol Biochem. 2017 May;81(5):922-930

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial.
Kamimura K, Suda T, Yokoo T, Kamimura H, Kanefuji T, Tsuchiya A, Takamura M, Kawai H, Waguri N, Yamagiwa S, Terai S.
BMC Cancer. 2017 May;17(1):322.

Prevention of esophageal stricture after endoscopic submucosal dissection using RNA-based silencing of carbohydrate sulfotransferase 15 in a porcine model.
Sato H, Sagara S, Nakajima N, Akimoto T, Suzuki K, Yoneyama H, Terai S, Yahagi N.
Endoscopy. 2017 May;49(5):491-497.

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
Kamimura K, Yokoo T, Kamimura H, Sakamaki A, Abe S, Tsuchiya A, Takamura M, Kawai H, Yamagiwa S, Terai S.
PLoS One. 2017 Jun;12(6):e0178991.

Evaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver.
Fujisawa K, Takami T, Matsuzaki A, Matsumoto T, Yamamoto N, Terai S, Sakaida I.
Sci Rep. 2017 Jun;7(1):2749.

Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population.
Ishihara R, Oyama T, Abe S, Takahashi H, Ono H, Fujisaki J, Kaise M, Goda K, Kawada K, Koike T, Takeuchi M, Matsuda R, Hirasawa D, Yamada M, Kodaira J, Tanaka M, Omae M, Matsui A, Kanesaka T, Takahashi A, Hirooka S, Saito M, Tsuji Y, Maeda Y, Yamashita H, Oda I, Tomita Y, Matsunaga T, Terai S, Ozawa S, Kawano T, Seto Y.
J Gastroenterol. 2017 Jul;52(7):800-808.

A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow-derived cells.
Matsuda T, Takami T, Sasaki R, Nishimura T, Aibe Y, Paredes BD, Quintanilha LF, Matsumoto T, Ishikawa T, Yamamoto N, Tani K, Terai S, Taura Y, Sakaida I.
Hepatol Commun. 2017 Jul 17;1(7):691-703.

YAP determines the cell fate of injured mouse hepatocytes in vivo.
Miyamura N, Hata S, Itoh T, Tanaka M, Nishio M, Itoh M, Ogawa Y, Terai S, Sakaida I, Suzuki A, Miyajima A, Nishina H.
Nat Commun. 2017 Jul 6;8:16017.

An Automated Self-Learning Quantification System to Identify Visible Areas in Capsule Endoscopy Images.
Hashimoto S, Ogihara H, Suenaga M, Fujita Y, Terai S, Hamamoto Y, Sakaida I.
J Med Syst. 2017 Aug;41(8):119.

Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study.
Azumi M, Suda T, Terai S, Akazawa K.
Intern Med. 2017;56(9):1001-1007.

Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post-marketing surveillance of tolvaptan in liver cirrhosis (START study).
Sakaida I, Terai S, Kurosaki M, Yasuda M, Okada M, Bando K, Fukuta Y.
Hepatol Res. 2017 Oct;47(11):1137-1146.

Changes in esophageal motility after endoscopic submucosal dissection for superficial esophageal cancer: a high-resolution manometry study.
Takahashi K, Sato Y, Takeuchi M, Sato H, Nakajima N, Ikarashi S, Hayashi K, Mizuno KI, Honda Y, Hashimoto S, Yokoyama J, Terai S.
Dis Esophagus. 2017 Nov 1;30(11):1-8.

Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma.
Honda H, Takamura M, Yamagiwa S, Genda T, Horigome R, Kimura N, Setsu T, Tominaga K, Kamimura H, Matsuda Y, Wakai T, Aoyagi Y, Terai S.
Sci Rep. 2017 Nov;7(1):15485.

Effect of Helicobacter pylori eradication on elder cases: Observational study in community-based medicine.
Maruyama M, Kamimura K, Hoshiyama A, Hoshiyama K, Hoshiyama M, Hoshiyama Y, Terai S.
World J Clin Cases. 2017 Dec 16;5(12):412-418.

Efficacy and Safety of Pancreas-Targeted Hydrodynamic Gene Delivery in Rats.
Ogawa K, Kamimura K, Kobayashi Y, Abe H, Yokoo T, Sakai N, Nagoya T, Sakamaki A, Abe S, Hayashi K, Ikarashi S, Kohisa J, Tsuchida M, Aoyagi Y, Zhang G, Liu D, Terai S.
Mol Ther Nucleic Acids. 2017 Dec;9:80-88.